Journal - Melody® Transcatheter Valve Demonstrates Encouraging Results in Study on Patients with Congenital Heart Disease

Clinical trial results published in this week?s Journal of the American College of Cardiology (JACC) describe six-month outcomes for patients using the Melody® Transcatheter Pulmonary Valve from Medtronic, Inc (NYSE: MDT) The valve is implanted through a catheter procedure instead of open-heart surgery in patients with congenital heart disease affecting the function of their pulmonary valve.The first-of-its kind device is currently under review by the U.S.